Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
4.045
-0.045 (-1.10%)
Jan 8, 2026, 1:07 PM EST - Market open
Voyager Therapeutics Market Cap
Voyager Therapeutics has a market cap or net worth of $224.9 million as of January 8, 2026. Its market cap has decreased by -27.64% in one year.
Market Cap
224.90M
Enterprise Value
30.92M
1-Year Change
-27.64%
Ranking
Category
Stock Price
$4.05
Market Cap Chart
Since November 11, 2015, Voyager Therapeutics's market cap has decreased from $456.60M to $224.90M, a decrease of -50.74%. That is a compound annual growth rate of -6.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 227.40M | 4.07% |
| Dec 31, 2025 | 218.50M | -29.45% |
| Dec 31, 2024 | 309.70M | -16.59% |
| Dec 29, 2023 | 371.30M | 57.66% |
| Dec 30, 2022 | 235.50M | 128.86% |
| Dec 31, 2021 | 102.90M | -61.59% |
| Dec 31, 2020 | 267.90M | -48.20% |
| Dec 31, 2019 | 517.20M | 69.02% |
| Dec 31, 2018 | 306.00M | -31.60% |
| Dec 29, 2017 | 447.40M | 31.43% |
| Dec 30, 2016 | 340.40M | -41.89% |
| Dec 31, 2015 | 585.80M | 28.30% |
| Nov 11, 2015 | 456.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 943.56B |
| Johnson & Johnson | 495.35B |
| AbbVie | 391.29B |
| UnitedHealth Group | 317.04B |
| AstraZeneca | 280.51B |
| Merck & Co. | 270.04B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |